0001477932-18-006021.txt : 20181217 0001477932-18-006021.hdr.sgml : 20181217 20181217095109 ACCESSION NUMBER: 0001477932-18-006021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171108 FILED AS OF DATE: 20181217 DATE AS OF CHANGE: 20181217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Climate Change Investigation, Innovation & Investment Company, LLC CENTRAL INDEX KEY: 0001759122 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55908 FILM NUMBER: 181237204 BUSINESS ADDRESS: STREET 1: 12 SAN RAFAEL AVE CITY: BELVEDERE STATE: CA ZIP: 94920 BUSINESS PHONE: 9252007127 MAIL ADDRESS: STREET 1: 12 SAN RAFAEL AVE CITY: BELVEDERE STATE: CA ZIP: 94920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp. CENTRAL INDEX KEY: 0001643301 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, FOIL & COATED PAPER BAGS [2673] IRS NUMBER: 371765151 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805-824-0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 FORMER COMPANY: FORMER CONFORMED NAME: Makkanotti Group Corp. DATE OF NAME CHANGE: 20150526 4 1 form4.xml FORM 4 X0306 4 2017-11-08-07:00 false 0001643301 Cure Pharmaceutical Holding Corp. CURR 0001759122 Climate Change Investigation, Innovation & Investment Company, LLC 12 SAN RAFAEL AVE BELVEDERE CA 94920 false false true false Common Stock 2018-07-07-06:00 4 M false 297288 0.886 A 3495932 D Warrant 7.00 2017-11-08-07:00 4 P false 50000 250000 A 2017-11-08-07:00 2020-11-08-07:00 Common Stock 50000 50000 D Warrant 1.00 2018-05-15-06:00 4 P false 148644 250000 A 2018-05-15-06:00 2021-05-15-06:00 Common Stock 148644 198644 D Conversion of Convertible Promissory Note. The conversion price is the lesser of $7.00 or the price per share of the latest closing of a debt or equity offering by the Issuer greater than $3,000,000. $250,000 is the principal amount paid for both a convertible note and the warrant on November 8, 2017. Exercise price per share equal to the lower of (a) $1.00 or (b) 125% of the price of a qualified offering, and to purchase up to a number of shares of common stock equal to 50% of the number of shares of common stock issuable upon conversion of such purchaser's note. The number of warrant shares are equal to fifty percent (50%) of the number of shares of common stock issued upon conversion of the note at the applicable conversion price under the note converted on 7/7/2018. $250,000 is the principal amount paid for both a convertible note and the warrant on May 15, 2018. /s/ James Farrell, Manager of Climate Change Investigation, Innovation and Investment Company, LLC 2018-12-13-07:00